Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Descriptor ID |
D029424
|
| MeSH Number(s) |
C08.381.495.389
|
| Concept/Terms |
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in this website by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 5 | 1 | 6 |
| 2004 | 3 | 0 | 3 |
| 2005 | 9 | 4 | 13 |
| 2006 | 8 | 0 | 8 |
| 2007 | 12 | 4 | 16 |
| 2008 | 16 | 2 | 18 |
| 2009 | 8 | 2 | 10 |
| 2010 | 13 | 3 | 16 |
| 2011 | 24 | 1 | 25 |
| 2012 | 15 | 2 | 17 |
| 2013 | 17 | 5 | 22 |
| 2014 | 7 | 4 | 11 |
| 2015 | 19 | 3 | 22 |
| 2016 | 21 | 7 | 28 |
| 2017 | 23 | 3 | 26 |
| 2018 | 38 | 3 | 41 |
| 2019 | 16 | 4 | 20 |
| 2020 | 19 | 3 | 22 |
| 2021 | 16 | 4 | 20 |
| 2022 | 38 | 0 | 38 |
| 2023 | 27 | 0 | 27 |
| 2024 | 18 | 4 | 22 |
| 2025 | 12 | 3 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities. Nat Commun. 2025 Oct 10; 16(1):9042.
-
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 Oct; 211(10):1794-1801.
-
CYP1B1 Mediates Cigarette Smoke-Induced Lipid Accumulation in Alveolar Type 2 Cells. FASEB J. 2025 Sep 30; 39(18):e71062.
-
Comorbidities as treatable traits of chronic airway diseases. Respir Med. 2025 Nov; 248:108333.
-
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2025 Aug; 13(8):687-697.
-
Frailty associates with respiratory exacerbations and mortality in the COPDGene cohort. Aging (Albany NY). 2025 Jul 03; 17(7):1590-1623.
-
A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease. JAMA. 2025 06 24; 333(24):2164-2175.
-
Practical strategies for achieving system change in the US: lessons and insights from the CONQUEST quality improvement programme. Prim Health Care Res Dev. 2025 Jun 23; 26:e50.
-
Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome. Sci Rep. 2025 Jun 06; 15(1):19892.
-
B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort. Front Immunol. 2025; 16:1508786.